MYRNA ALICEA: Open Payments
NPI 1619099397 · LANGHORNE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$485 in 14 payments from 10 companies in 2025. Trend: 2023 $499 · 2024 $721 · 2025 $485
Food & beverage: $485
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 1 | $118 |
| Medtronic, Inc. | 1 | $113 |
| Kestra Medical Technology Services, Inc. | 2 | $76 |
| Novartis Pharmaceuticals Corporation | 2 | $37 |
| Baxter Healthcare | 2 | $37 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 2 | $33 |
| Boston Scientific Corporation | 1 | $23 |
| Amgen Inc. | 1 | $17 |
| PFIZER INC. | 1 | $16 |
| Novo Nordisk Inc | 1 | $15 |
Products named: FASENRA, COREVALVE EVOLUT R, Assure WCD, LEQVIO, Hillrom - Cardiac Ambulatory Monitor, LifeVest, WATCHMAN FLX, REPATHA.
Industry payments across PA — which companies pay providers there.
